Evaluation of MRI/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches

Table 2

Distribution of MRI/TRUS fusion-guided biopsy target lesions and PCa in TR and TP cohorts.

localization	Transrectal		Transperineal
	All lesions ()	Lesions with ()	All lesions ()	Lesions with ()
AFS	9/79; (11.4%)	6/31; (19.4%)	27/75; (36%)	24/56; (42.9%)
Anterior	18/79; (22.8%)	6/31; (19.4%)	32/75; (42.7%)	20/56; (35.7%)
Posterior	52/79; (65.8%)	19/31; (61.2%)	16/75; (21.3%)	12/56; (21.4%)

with tumor-positive cores after fusion-guided and systematic biopsy. AFS: anterior fibromuscular stroma; PCa: prostate cancer.